Tag: ImmTOR

FDA puts clinical hold on Selecta Biosciences SEL-302 phase 1/2 trial

pallavi123- November 27, 2021

Selecta Biosciences said that the US Food and Drug Administration (FDA) has imposed a clinical hold on its phase 1/2 clinical trial of SEL-302 gene ... Read More